Sastasundar Ventures Limited — PPTs, 19-02-2025: Investor Presentation

**Financial Highlights:** SastaSundar reported Q3 FY25 revenue from operations of ₹279.8 Cr, down 23.7% year-on-year from ₹366.8 Cr, and a slight increase of 6.2% sequentially. The gross profit also declined significantly by 46.0% to ₹16.8 Cr, with a gross profit margin of 6.0%, compared to 8.5% in Q3 FY24. EBITDA for the quarter was impacted severely, resulting in a loss of ₹25.2 Cr. This reflects a challenging operational environment, hindering profitability.

**Strategic Initiatives and Growth Drivers:** The company continues to focus on integrating its B2C and B2B digital health platforms and enhancing service offerings, which is aimed at improving customer access and satisfaction.

**Business Developments:** The investor presentation highlighted ongoing initiatives to diversify revenue streams and optimize supply chain efficiencies, which may help mitigate the adverse effects on financial performance.

**Market Position and Competitive Advantage:** Although facing revenue headwinds, SastaSundar retains a unique position in the healthcare space with a commitment to service quality and technology-driven solutions, which could be advantageous in a recovering market.

**Investor Implications:** Current financial challenges present risks, but the alignment of operational strategies with market trends could pave the way for recovery. Investors should monitor performance closely for signs of improvement in subsequent quarters.